Comparing the Cost of Administering and Monitoring Vancomycin and Daptomycin Through a Home Infusion Pharmacy
https://doi.org/10.70776/JECB9600
Katherine Yang, PharmD, BCPS | Wendy Morimoto, PharmD | Kristina Wong, PharmD | Mehrnaz Zahiri, PharmD | Meredith Silverman, MD
This study evaluates the cost differences between administering and monitoring vancomycin and daptomycin in a home infusion pharmacy (HIP) setting. Both antibiotics are widely used for treating methicillin-resistant Staphylococcus aureus (MRSA) and other gram-positive infections in outpatient parenteral antibiotic therapy (OPAT), but vancomycin requires more intensive therapeutic monitoring than daptomycin. The study aims to quantify pharmacist time spent monitoring patients, lab costs, and overall drug administration costs associated with each therapy in a HIP serving 16 medical centers in Northern California.